MEI Pharma, Inc.

MEIPNASDAQHealthcare

$3.07

+$0.29(+10.43%)

Market Cap$20452012

P/E Ratio—

52W High$9

52W Low$1.46

Avg Volume1.5M

Open$2.89

Beta0.22

Net Income Financials Revenue

MEI Pharma, Inc. (MEIP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MEIP · net income · updated Jun 9, 2026

Core profitability metrics

MEIP · net income · margin · TTM · CAGR

Net income was −$15.9M for FY2025 (fiscal year ending 2025-06-30), down 189.7% year-over-year. Net profit margin was —. Based on available data, MEI Pharma, Inc. has been profitable since at least 2017.

FY2025 Net Income−$15.9M▼ -189.7% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin——

YoY Change-189.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2017

▸ FMP /income-statement · Annual · MEIP net income history · MEIP profit margin

Annual net income data

MEIP · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$15.9M▼ 189.7%—$0

FY2024$17.8M▲ +155.8%27.2%$65.3M

FY2023Loss−$31.8M▲ +41.5%-65.2%$48.8M

FY2022Loss−$54.5M▼ 31.8%-133.8%$40.7M

FY2021Loss−$41.3M▲ +12.4%-161.8%$25.5M

Net income vs peers (Healthcare)

MEIP vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

MEI Pharma, Inc. (MEIP) reported net income of −$15.9M for FY2025 (fiscal year ending 2025-06-30), down 189.7% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, MEI Pharma, Inc. has been profitable since at least 2017. Net income reached a peak of $17.8M in FY2024. Data available for 15 fiscal years.

MEI Pharma, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "MEI Pharma, Inc. net worth" — the company's market capitalization is a separate figure from MEIP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

MEIP net income · 4 questions

MEI Pharma, Inc. is not currently profitable on an annual basis. The company reported a net loss of $15.9M for FY2025.

is MEIP profitabledoes MEIP make a profitMEIP profitabilityMEIP profitable company

▸ Source: FMP /income-statement · GAAP · MEI Pharma, Inc. · MEI Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026